Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.
Mentions
1 mention · latest on 2 Sept 2026
| Sangamo Bankruptcy (SGMOQ) | - | 2 Sept 2026 |